Evidence map›Paper›PMID 21987784›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Hydroxyurea induces de novo copy number variants in human cells.

Martin F Arlt, Alev Cagla Ozdemir, Shanda R Birkeland, Thomas E Wilson, Thomas W Glover

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Myeloproliferative Neoplasms: Challenging Dogma.Journal of clinical medicine · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Martin F ArltDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA.
Alev Cagla Ozdemir
Shanda R Birkeland
Thomas E Wilson
Thomas W Glover
University of Michigan–Ann Arbor · US

Funding

Environmental Risk Factors for Copy Number Variation in Human ChromosomesRC1ES018672 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GLOVER, THOMAS W, WILSON, THOMAS EDWARD · 2009 to 2010
$986k
NIEHS NIH HHS RC1 ES018672NIEHS NIH HHS RC1-ES018672
6 · The paper itself

Abstract

Copy number variants (CNVs) are widely distributed throughout the human genome, where they contribute to genetic variation and phenotypic diversity. Spontaneous CNVs are also a major cause of genetic and developmental disorders and arise frequently in cancer cells. As with all mutation classes, genetic and environmental factors almost certainly increase the risk for new and deleterious CNVs. However, despite the importance of CNVs, there is limited understanding of these precipitating risk factors and the mechanisms responsible for a large percentage of CNVs. Here we report that low doses of hydroxyurea, an inhibitor of ribonucleotide reductase and an important drug in the treatment of sickle cell disease and other diseases induces a high frequency of de novo CNVs in cultured human cells that resemble pathogenic and aphidicolin-induced CNVs in size and breakpoint structure. These CNVs are distributed throughout the genome, with some hotspots of de novo CNV formation. Sequencing revealed that CNV breakpoint junctions are characterized by short microhomologies, blunt ends, and short insertions. These data provide direct experimental support for models of replication-error origins of CNVs and suggest that any agent or condition that leads to replication stress has the potential to induce deleterious CNVs. In addition, they point to a need for further study of the genomic consequences of the therapeutic use of hydroxyurea.

Indexed as

Antisickling AgentsAphidicolinBase SequenceCells, CulturedChromosomes, Human, Pair 3DNA BreaksDNA Copy Number VariationsDNA ReplicationEnzyme InhibitorsHumansHydroxyureaMolecular Sequence DataPolymorphism, Single NucleotideRibonucleotide ReductasesAntisickling AgentsAphidicolinEnzyme InhibitorsHydroxyureaRibonucleotide Reductases

Identifiers

PMID21987784
PMCPMC3198378
OpenAlexW2029579124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.